The Novasight Hybrid System enables simultaneous, co-registered coronary artery imaging with both intravascular ultrasound and optical coherence tomography.
The publication of ISO 10993-23:2021 marks a paradigm shift in prioritizing in-vitro testing alternatives within the medical device biocompatibility space.
Nick Hibbard, In-Vitro Scientific Research Fellow at WuXi AppTec Medical Device Testing07.22.21
Tubing is incorporated into a variety of medical technologies, which is why the demands on manufacturers of the components are increasing substantially.
Diagnostic imaging is gaining the attention of many in healthcare as the technologies shrink in size and become available to those outside the hospital.